Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Michael Schmitz is an analyst at Guggenheim. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/26/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 10/28/2024 | RVMD | Buy Now | Revolution Medicines | $38.45 | 113.26% | Michael Schmitz42% | $72 → $82 | Maintains | Buy | Get Alert |
| 10/01/2024 | MRUS | Buy Now | Merus | $46.98 | 136.27% | Michael Schmitz42% | $93 → $111 | Maintains | Buy | Get Alert |
| 08/02/2024 | BPMC | Buy Now | Blueprint Medicines | $94.01 | 46.79% | Michael Schmitz42% | $130 → $138 | Maintains | Buy | Get Alert |
| 05/28/2024 | MRUS | Buy Now | Merus | $46.98 | 97.96% | Michael Schmitz42% | $57 → $93 | Maintains | Buy | Get Alert |
| 11/20/2023 | ARVN | Buy Now | Arvinas | $8.51 | 370.04% | Michael Schmitz42% | → $40 | Upgrade | Neutral → Buy | Get Alert |
| 02/28/2023 | RVMD | Buy Now | Revolution Medicines | $38.45 | -1.17% | Michael Schmitz42% | → $38 | Reiterates | → Buy | Get Alert |
| 01/03/2023 | FATE | Buy Now | Fate Therapeutics | $0.92 | — | Michael Schmitz42% | — | Downgrade | Buy → Neutral | Get Alert |
| 11/02/2022 | BPMC | Buy Now | Blueprint Medicines | $94.01 | -9.58% | Michael Schmitz42% | $110 → $85 | Maintains | Buy | Get Alert |
| 01/03/2022 | BPMC | Buy Now | Blueprint Medicines | $94.01 | 29.77% | Michael Schmitz42% | $120 → $122 | Maintains | Buy | Get Alert |
| 11/29/2021 | BPMC | Buy Now | Blueprint Medicines | $94.01 | 27.65% | Michael Schmitz42% | $122 → $120 | Maintains | Buy | Get Alert |
| 10/28/2021 | BPMC | Buy Now | Blueprint Medicines | $94.01 | 29.77% | Michael Schmitz42% | $120 → $122 | Maintains | Buy | Get Alert |
| 08/10/2021 | IMGO | Buy Now | Imago BioSciences | — | — | Michael Schmitz42% | → $35 | Initiates | → Buy | Get Alert |
| 04/29/2021 | BPMC | Buy Now | Blueprint Medicines | $94.01 | 17.01% | Michael Schmitz42% | $125 → $110 | Maintains | Buy | Get Alert |
| 10/29/2020 | BPMC | Buy Now | Blueprint Medicines | $94.01 | 27.65% | Michael Schmitz42% | $106 → $120 | Maintains | Buy | Get Alert |
| 09/23/2020 | BPMC | Buy Now | Blueprint Medicines | $94.01 | 12.75% | Michael Schmitz42% | $94 → $106 | Maintains | Buy | Get Alert |
| 01/06/2020 | NOVA | Buy Now | Sunnova Energy Intl | $0.36 | 4014.1% | Michael Schmitz42% | → $15 | Initiates | → Buy | Get Alert |
| 03/16/2018 | EEQ | Buy Now | Enbridge Energy | — | — | Michael Schmitz42% | — | Downgrade | Buy → Neutral | Get Alert |
| 03/16/2018 | EEP | Buy Now | Enbridge Energy Partners | — | — | Michael Schmitz42% | — | Downgrade | Buy → Neutral | Get Alert |
| 05/30/2017 | AMGP | Buy Now | Antero Midstream GP | — | — | Michael Schmitz42% | → $27 | Initiates | → Buy | Get Alert |
| 01/20/2017 | TCP | Buy Now | TC Pipelines | — | — | Michael Schmitz42% | → $61 | Initiates | → Neutral | Get Alert |
| 12/19/2016 | APC | Buy Now | Anadarko Petroleum | — | — | Michael Schmitz42% | → $85 | Initiates | → Buy | Get Alert |
| 12/19/2016 | MMP | Buy Now | Magellan Midstream | — | — | Michael Schmitz42% | → $80 | Initiates | → Buy | Get Alert |
| 11/01/2016 | EEQ | Buy Now | Enbridge Energy Management LLC Shares repstg limited liability company interests | — | — | Michael Schmitz42% | — | Assumes | → Buy | Get Alert |
| 11/01/2016 | EEP | Buy Now | Enbridge Energy, L.P. Class A Common Units | — | — | Michael Schmitz42% | — | Assumes | → Buy | Get Alert |
| 07/13/2016 | MMP | Buy Now | Magellan Midstream | — | — | Michael Schmitz42% | — | Initiates | → Buy | Get Alert |
| 05/06/2016 | TCP | Buy Now | TC Pipelines | — | — | Michael Schmitz42% | $52 → $54 | Downgrade | Buy → Neutral | Get Alert |
| 11/11/2015 | TCP | Buy Now | TC Pipelines | — | — | Michael Schmitz42% | — | Upgrade | Neutral → Buy | Get Alert |
| 10/16/2014 | MMP | Buy Now | Magellan Midstream | — | — | Michael Schmitz42% | → $90 | Upgrade | → Buy | Get Alert |
| 05/01/2014 | TCP | Buy Now | TC Pipelines | — | — | Michael Schmitz42% | — | Downgrade | Buy → Neutral | Get Alert |
| 04/11/2014 | MMP | Buy Now | Magellan Midstream | — | — | Michael Schmitz42% | $71 → $74 | Downgrade | Buy → Neutral | Get Alert |
| 02/10/2014 | TCP | Buy Now | TC Pipelines | — | — | Michael Schmitz42% | → $54 | Upgrade | Neutral → Buy | Get Alert |
| 02/06/2014 | MMP | Buy Now | Magellan Midstream | — | — | Michael Schmitz42% | $64 → $71 | Upgrade | Neutral → Buy | Get Alert |
| 11/04/2013 | MMP | Buy Now | Magellan Midstream | — | — | Michael Schmitz42% | — | Downgrade | → Neutral | Get Alert |
| 08/08/2013 | MMP | Buy Now | Magellan Midstream | — | — | Michael Schmitz42% | $55 → $60 | Upgrade | Neutral → Buy | Get Alert |
| 07/25/2013 | TCP | Buy Now | TC Pipelines | — | — | Michael Schmitz42% | → $51 | Downgrade | Buy → Neutral | Get Alert |
| 05/30/2013 | TCP | Buy Now | TC Pipelines | — | — | Michael Schmitz42% | $48 → $51 | Upgrade | Neutral → Buy | Get Alert |
| 03/11/2013 | TCP | Buy Now | TC Pipelines | — | — | Michael Schmitz42% | → $48 | Downgrade | Buy → Neutral | Get Alert |
| 05/02/2012 | EEQ | Buy Now | Enbridge Energy Management | — | — | Michael Schmitz42% | $36 → $35 | Maintains | Buy | Get Alert |
| 05/02/2012 | EEP | Buy Now | Enbridge Energy Partners Class A | — | — | Michael Schmitz42% | $36 → $35 | Maintains | Buy | Get Alert |
| 03/12/2012 | MMP | Buy Now | Magellan Midstream Partners | — | — | Michael Schmitz42% | → $37.5 | Downgrade | Buy → Neutral | Get Alert |
| 02/08/2012 | MMP | Buy Now | Magellan Midstream Partners | — | — | Michael Schmitz42% | $33.75 → $37.5 | Upgrade | Neutral → Buy | Get Alert |
